21 C.F.R. § 556.346

Laidlomycin.

Last amended: 2019Year: 2026Length: 49 wordsSubsections: 3Official source

Cite as 21 C.F.R. § 556.346 (2026)

(a) Acceptable daily intake (ADI). The ADI for total residue of laidlomycin is 7.5 µg/kg of body weight per day. (b) Tolerances. The tolerance for laidlomycin (marker residue) is: (1) Cattle. Liver (target tissue): 0.2 ppm. (2) [Reserved] (c) Related conditions of use. See § 558.305 of this chapter.
Cross-references to the CFR
558.305
21 C.F.R. § 556.346: Laidlomycin. | Justis AI